abil
cell
form
releas
multipl
class
extracellular
vesicl
ev
increasingli
wellrecogn
phenomenon
ev
best
known
mediat
intercellular
commun
howev
recent
issu
natur
keller
et
al
show
function
decoy
mitig
bacteri
toxin
bacterium
staphylococcu
aureu
aureu
origin
describ
sir
alexand
ogston
ogston
sinc
strain
aureu
resist
differ
antibiot
first
penicillin
methicillin
began
emerg
methicillinresist
aureu
mrsa
endem
mani
hospit
one
lead
caus
infect
contract
healthcar
set
klein
et
al
thu
clear
need
better
understand
process
bacteri
infect
especi
host
cell
respond
potenti
deadli
threat
mammalian
organ
combat
bacteri
infect
rapidli
induc
innat
immun
respons
recent
issu
natur
keller
et
al
describ
previous
unknown
mechan
innat
immun
involv
abil
cell
produc
exosom
specif
class
extracellular
vesicl
ev
function
protect
barrier
prevent
bacteri
toxin
reach
target
cell
exosom
small
ev
nm
diamet
origin
endolysosom
traffick
pathway
intralumin
vesicl
within
multivesicular
bodi
releas
cell
multivesicular
bodi
fuse
plasma
membran
microvesicl
mv
repres
second
major
class
ev
larger
exosom
mm
diamet
deriv
result
outward
bud
releas
plasma
membran
exosom
mv
engag
transfer
associ
protein
nucleic
acid
cargo
cell
thu
alter
cell
behavior
form
intercellular
commun
studi
extens
context
cancer
shown
ev
shed
cancer
cell
interact
neighbor
cancer
cell
well
noncancer
cell
resid
either
local
within
tumor
microenviron
distant
site
interact
promot
aggress
phenotyp
includ
acceler
cell
growth
therapi
resist
invas
metastasi
latifkar
et
al
recent
exosom
releas
melanoma
cell
also
shown
engag
inactiv
immun
cell
thu
enabl
tumor
cell
evad
immun
respons
chen
et
al
work
describ
keller
et
al
shed
new
light
ev
particular
exosom
produc
cell
mechan
protect
pathogen
agent
act
cellular
decoy
discoveri
stem
earlier
find
show
mice
cell
deplet
autophagyrel
protein
far
suscept
mrsa
strain
releas
poreform
alphatoxin
compar
wildtyp
mice
cell
maurer
et
al
keller
et
al
determin
mechanist
basi
mediat
effect
show
depend
chang
express
level
metalloproteas
alphatoxin
known
bind
express
surfac
cell
mediat
format
pore
interestingli
cell
lack
level
detect
plasma
membran
increas
led
correspond
increas
alphatoxinmedi
pore
format
cell
death
sinc
autophagyrel
machineri
demonstr
regul
exosom
biogenesi
guo
et
al
author
suspect
decreas
sensit
cell
mrsa
influenc
releas
exosom
contain
inde
cell
express
suffici
amount
found
produc
larg
quantiti
exosom
contain
metalloproteas
cell
deplet
releas
far
fewer
exosom
lead
idea
shed
greater
number
exosom
contain
creat
protect
barrier
surround
cell
thu
alphatoxin
releas
mrsa
strain
vicin
cell
would
like
bind
exosom
caus
toxin
undergo
oligomer
becom
inactiv
therebi
highlight
form
innat
immun
previous
appreci
author
next
examin
whether
format
releas
exosom
contain
might
increas
cell
treat
varieti
differ
bacteria
keller
et
al
result
experi
show
aureu
well
pathogen
includ
streptococcu
pneumonia
citrobact
rodentium
salmonella
enterica
similarli
capabl
enhanc
product
exosom
suggest
releas
ev
repres
gener
mechan
use
cell
reduc
infect
bacteri
pathogen
author
carri
two
addit
vivo
experi
greatli
solidifi
find
first
experi
proteom
analysi
perform
exosom
isol
plasma
collect
mrsainfect
mice
result
elegantli
show
exosom
origin
liver
hotspot
mrsa
infect
surewaard
et
al
second
experi
author
want
see
whether
exosom
protect
vivo
exosom
isol
blood
donor
mice
treat
attenu
form
aureu
inject
recipi
mice
expos
lethal
dose
bacteria
control
anim
rapidli
die
infect
anim
receiv
exosom
treatment
live
significantli
longer
taken
collect
result
studi
suggest
inject
exosom
potenti
even
liposom
contain
duong
et
al
could
provid
new
strategi
combat
bacteri
infect
might
offer
especi
use
treatment
individu
compromis
immun
system
antibiot
resist
develop
conclus
studi
keller
et
al
provid
strike
novel
exampl
exosom
impact
biolog
respons
surpris
way
case
serv
decoy
agent
protect
host
cell
bacteri
poreform
toxin
figur
find
join
grow
list
exampl
exosom
ev
gener
either
act
protect
parent
cell
deriv
incom
signal
otherwis
would
compromis
cell
surviv
provid
mechan
intercellular
commun
confer
cell
biolog
advantag
case
action
vesicl
deleteri
effect
regard
diseas
progress
patholog
disord
includ
among
exampl
abil
exosom
shed
aggress
cancer
cell
block
immun
surveil
thu
interfer
immun
therapi
chen
et
al
action
larger
ev
ie
mv
stimul
vegf
receptor
endotheli
cell
activ
initi
stage
tumor
angiogenesi
manner
insensit
antiangiogenesi
drug
bevacizumab
feng
et
al
howev
case
like
studi
describ
provid
benefici
effect
health
organ
like
mani
instanc
ev
use
provid
benefit
surviv
advantag
parent
cell
exampl
light
strike
challeng
face
due
outbreak
intrigu
question
whether
cell
might
also
use
exosom
mitig
viral
infect
given
everincreas
appreci
biolog
signific
good
bad
consequ
critic
address
fundament
question
regard
biogenesi
exosom
ev
specif
cellular
biolog
context
also
increasingli
import
design
novel
strategi
manipul
product
shed
either
increas
number
advantag
good
health
inhibit
gener
contribut
diseas
metastat
cancer
neurodegen
disord
upon
exposur
aureu
cell
releas
larg
amount
exosom
metalloproteas
surfac
alphatoxin
releas
aureu
bind
exosom
becom
oligomer
inactiv
provid
mechan
innat
immun
effect
diminish
virul
pathogen
bacteria
ie
mrsa
